Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Co-Diagnostics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 88
- −7 vs. Q1 2021
- Shares held
- 7.25M
- −1.75M (−19.5%) vs. Q1 2021
- Total value
- $59.8M
- −$26.0M (−30.3%) vs. Q1 2021
- New holders
- 22
- 20 more added
- Sold out
- 29
- 32 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CODX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $1.85M |
| Q1 2026 | 14 | $91.5K |
| Q4 2025 | 30 | $940.4K |
| Q3 2025 | 33 | $1.93M |
| Q2 2025 | 35 | $1.44M |
| Q1 2025 | 38 | $1.81M |
| Q4 2024 | 37 | $4.29M |
| Q3 2024 | 36 | $5.52M |
| Q2 2024 | 44 | $5.81M |
| Q1 2024 | 39 | $4.89M |
| Q4 2023 | 47 | $6.25M |
| Q3 2023 | 46 | $4.83M |
| Q2 2023 | 45 | $4.93M |
| Q1 2023 | 55 | $8.06M |
| Q4 2022 | 61 | $14.8M |
| Q3 2022 | 66 | $20.0M |
| Q2 2022 | 71 | $40.9M |
| Q1 2022 | 82 | $42.7M |
| Q4 2021 | 78 | $63.7M |
| Q3 2021 | 78 | $77.6M |
| Q2 2021 | 88 | $59.8M |
| Q1 2021 | 95 | $85.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Co-Diagnostics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American International Group, Inc. | 0 | $0 | 0.00% | −15,472−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,969−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −13,798−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,758−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −10,425−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −7,152−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −5,117−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −4,051−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −2,956−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,291−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −1,942−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −1,234−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −1,189−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −779−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −455−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |